EMEA-001526-PIP01-13-M03

Key facts

Invented name
Natpar
Active substance
Recombinant parathyroid hormone
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0136/2019
PIP number
EMEA-001526-PIP01-13-M03
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of hypoparathyroidism
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Shire Pharmaceuticals Ireland Limited

Tel. +44 1256 894959
E-mail: medinfoEMEA@shire.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating